National consensus on diagnosis and treatment of osteoarthritis
PDF EN
PDF BG (Български)

Keywords

OA
osteoarthritis
consensus

How to Cite

[1]
Stoilov, R., Georgiev, T. and Ivanova, M. 2021. National consensus on diagnosis and treatment of osteoarthritis. Rheumatology (Bulgaria). 28, S1 (Sep. 2021), 46-63. DOI:https://doi.org/10.35465/29.S.2021.pp26-45.

Abstract

Not applicable.

https://doi.org/10.35465/29.S.2021.pp26-45
PDF EN
PDF BG (Български)

References

  1. Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006; 31.5:465-76.
  2. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 1986 Aug;29(8):1039-49.
  3. Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis and cartilage. 2007; 15:A1-A56.
  4. Anderson JW, Nicolosi RJ, et Borzelleca JF. Glucosamine effects in humans: A review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005; 43:187–201.
  5. Anderson, Jennifer J., and David T. Felson. "Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I) evidence for an association with overweight, race, and physical demands of work." American journal of epidemiology. 1988;128.1:179-189.
  6. Andrianakos AA, Kontelis LK, Karamitsos DG, et al.; ESORDIG Study Group. Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol 2006; 33:2507–13.
  7. Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T. Sensitization in patients with painful knee osteoarthritis. Pain. 2010;149.3:573-581.
  8. Balazs EA, Laurent TC, et Jeanloz RW. Nomenclature of hyaluronic acid. Biochemical Journal 1986; 235.3:903.
  9. Bartley EJ, King CD, Sibille KT, Cruz‐Almeida Y, Riley III JL, Glover TL, et al. Enhanced pain sensitivity among individuals with symptomatic knee osteoarthritis: potential sex differences in central sensitization. Arthritis care & research 2016;68.4:472-480.
  10. Bjordal JM, Johnson MI, Lopes-Martins RA, et al. Short-term efficacy of physical interventions in osteoarthritis knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials. BMC Musculoskeletal Disord 2007; 8:51.
  11. Bookman A, Williams K, Shainhouse J. Effect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: a randomized controlled trial. CMAJ. 2004; 171(4 ):333–8.
  12. Brosseau L. Efficacy of transcutaneous electrical nerve stimulation for osteo­arthritis of the lower extremities: A meta-analysis. Phys Ther Rev 2004; 9:213-233.
  13. Bruyere O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum, 2014; 44:253-263.
  14. Bruyère O, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis—from evidence-based medicine to the real-life setting. Seminars in arthritis and rheumatism. 2016; 45.4:3-11.
  15. Bruyere O, Pavelka K, Rovati LC, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials Osteoarthritis Cartilage. 2008; 16:254-260.
  16. Buckwalter JA, Mankin HJ, Grodzinsky AJ. Articular cartilage and osteoarthritis. Instr Course Lect. 2005; 54:465–80.
  17. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions Instr Course Lect. 1998; 47:477–86.
  18. Caccia S, Casartelli M, Grimaldi A, Losa E, de Eguileor M, Pennacchio F, et al. Unexpected similarity of intestinal sugar absorption by SGLT1 and apical GLUT2 in an insect (Aphidius ervi, Hymenoptera) and mammals. Am J Physiol Regul Integr Comp Physiol. 2007; 292:R2284–R2291
  19. Cepeda MS, Camargo F, Zea C, Valencia L Tramadol for osteoarthritis. Cochrane Database Syst Rev. 2006 ;3:CD005522.
  20. Chan F, Lanas A, Scheiman J, Berger M, Nguyen H, Goldstein J. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Lancet. 2010; 376:173–9.
  21. Cimmino MA, Sarzi-Puttini P, Scarpa R, Caporali R, Parazzini F, Zaninelli A, et al. Clinical presentation of osteoarthritis in general practice: determinants of pain in Italian patients in the AMICA Study. Semin Arthritis Rheum. 2005;35(suppl 1):17–23.
  22. Clegg D, Reda D, Harris C, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med. 2006; 354:795-808.
  23. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL. The global burden of hip and
  24. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94. J Rheumatol. 2006; 33:2271–2279.
  25. Eyre D. Collagen of articular cartilage. Arthritis Res. 2002; 4(1):30–5.
  26. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000; 133(8):635–46.
  27. Finan PH, Buenaver LF, Bounds SC, Hussain S, Park RJ, Haque UJ, et al. Discordance between pain and radiographic severity in knee osteoarthritis: findings from quantitative sensory testing of central sensitization. Arthritis & Rheumatology 2013;65.2:363-372.
  28. G. Herrero-Beaumont, J.A. Ivorra, M. Del Carmen Trabado, F.J. Blanco, P. Benito, E. Martín-Mola, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007; 56:555-567.
  29. Georgiev T, Ivanova М, Stoilov R. Recent trends in the pahogenic mechanism of osteoarthritis. Revmatologiia (Bulgaria). 2013; 21:3:49-53.
  30. Henrotin Y, Marty M, et Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis?. Maturitas. 2014; 78.3:184-187.
  31. Hepper TC, et al. The efficacy and duration of intra-articular corticosteroid injection for knee osteoarthritis: a systematic review of level I studies. JAAOS-Journal of the American Academy of Orthopaedic Surgeons 2009; 17.10:638-646.
  32. Herndon JH, Davidson SM, Apazidis A: Recent socioeconomic trends in orthopaedic practice. J Bone Joint Surg Am. 2001; 83-A(7):1097–1105.
  33. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Arthritis Care Res, 2012; 64:465-474.
  34. Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee Arthritis Care Res (Hoboken). 2012; 64:465-474.
  35. Hochberg. Rheumatology, Sixth Edition. Elsevier, 2015.
  36. Hunt R, Lanas A, Stichtenoth D, Scarpignato C. Myths and facts in the use of anti-inflammatory drugs. Ann Med. 2009; 41:423–37.
  37. Ibrahim A, Gilzad-Kohan MH, Aghazadeh-Habashi A, et Jamali F. Absorption and bioavailability of glucosamine in the rat. J Pharm Sci 2012; 101:2574–2583.
  38. J.Y. Reginster, R. Deroisy, L.C. Rovati, R.L. Lee, E. Lejeune, O. Bruyere, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001; 357:251-256.
  39. Jordan KM, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Annals of the rheumatic diseases 2003; 62.12:1145-1155.
  40. K. Pavelká, J. Gatterová, M. Olejarová, S. Machacek, G. Giacovelli, L.C. Rovati. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002; 162:2113-2123
  41. Kapoor M, Mahomed NN, editors. Osteoarthritis: Pathogenesis, diagnosis, available treatments, drug safety, regenerative and precision medicine. Springer; 2015 Jul 20.
  42. knee osteoarthritis: estimates from the global burden of disease 2010 study. Annals of the rheumatic diseases. 2014; 73(7):1323-30.
  43. Kuster MS, Wood GA, Stachowiak GW, Gächter A. Joint load considerations in total knee replacement. The Journal of bone and joint surgery. British volume. 1997; 79(1):109-13.
  44. Largo R, Alvarez-Soria MA, Diez-Ortego I, Calvo E, Sanchez-Pernaute O, Egido J, et al. Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage. 2003; 11:290–298.
  45. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010; 30:357-363.
  46. Li G, et al. Subchondral bone in osteoarthritis: insight into risk factors and microstructural changes. Arthritis Res Ther. 2013; 15(6):223.
  47. Lin YC, Liang YC, Sheu MT, Hsieh MS, Chen TF, et Chen CH. Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways. Rheumatol Int. 2008; 28:1009–1016.
  48. Loeser, Richard F., et al. "Osteoarthritis: a disease of the joint as an organ." Arthritis & Rheumatism 64.6 (2012): 1697-1707.
  49. McAlindon T, Formica M, Schmid CH, Fletcher J. Changes in barometric pressure and ambient temperature influence osteoarthritis pain. The American journal of medicine. 2007;120.5:429-434.
  50. McAlindon TE, Bannuru R, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and cartilage. 2014; 22(3):363-88.
  51. McAlindon TE, Cooper C, Kirwan JR, Dieppe PA . Knee pain and disability in the community. Br J Rheumatol . 1992;31:189–192.
  52. McAlindon TE, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. Jama 2017; 317.19:1967-1975.
  53. Mikesky AE, Mazzuca SA, Brandt KD, Perkins SM, Damush T, Lane KA. Effects of strength training on the incidence and progression of knee osteoarthritis. Arthritis Care & Research: Official Journal of the American College of Rheumatology. 2006; 55(5):690-9.
  54. National Clinical Guideline Centre UK. Osteoarthritis: care and management in adults. 2014.
  55. National Clinical Guideline Centre. Osteoarthritis care and management in adults: methods, evidence and recommendations. London, UK: National Institute for Health and Care Excellence; February 2014. Report No.: CG177.
  56. Nuesch E, Dieppe P, Reichenbach S, et al.; All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ. 2011; 342:d1165.
  57. O’Reilly SC, Muir KR, Doherty M. Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial. Annals of the rheumatic diseases. 1999 ;58(1):15-9.
  58. Osteoarthritis: A Serious Disease, in: White Paper Submitted to the U.S. Food and Drug Administration 2016, Pre Competitive Consortium for Osteoarthritis Osteoarthritis Research Society International: https://www.oarsi.org/sites/default/files/docs/2016/oarsi_white_paper_oa_serious_disease_121416_1.pdf.
  59. Paliwal S and Mitragotri S. Therapeutic opportunities in biological responses of ultrasound. Ultrasonics 2008; 48:271–278.
  60. Peat, G., R. McCarney, and P. Croft. "Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care." Annals of the rheumatic diseases. 2001;60.2:91-97.
  61. Perrot S, Poiraudeau S, Kabir-Ahmadi M, Rannou F. "Correlates of pain intensity in men and women with hip and knee osteoarthritis. Results of a national survey: The French ARTHRIX study." The Clinical journal of pain. 2009;25.9:767-772.
  62. Poole AR, et al. Composition and structure of articular cartilage: a template for tissue repair.Clin Orthop Relat Res. 2001; 391:S26–33.
  63. Raffa R, Friederichs E. The basic science aspect of tramadol hydrochloride. Pain Rev. 1996; 3:249–71.
  64. Reginster JY, et al. Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Annals of the rheumatic diseases 2017; annrheumdis-2016.
  65. Richard FL, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis & Rheumatism. 2012; 64.6:1697-1707.
  66. Richette P, Latourte A, et Frazier A. Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend?. Expert opinion on drug safety 2015; 14.8:1259-1268.
  67. Roos EM, Juhl CB. Osteoarthritis 2012 year in review: rehabilitation and outcomes. Osteoarthritis and cartilage. 2012; 20(12):1477-83.
  68. Roth S, Shainhouse J. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004; 164:2017–23.
  69. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham III CO, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2008; 58(10):3183-91.
  70. Setnikar I, et Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung. 2001; 51,699–725.
  71. Simon L, Grierson L, Naseer Z, Bookman A, Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009; 143:238–45.
  72. Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. The Cochrane database of systematic reviews. 2015; 1:CD005614.
  73. Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular cartilage: structure, composition, and function. Sports Health Multidiscip Approach. 2009; 1(6):461–8.
  74. Uitterlinden EJ, Jahr H, Koevoet JL, Jenniskens YM, Bierma-Zeinstra S M, Degroot J, et al. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage. 2006; 14:250–257.
  75. Van der Esch, Martin, Monique Heijmans, and Joost Dekker. Factors contributing to possession and use of walking aids among persons with rheumatoid arthritis and osteoarthritis. Arthritis Care & Research: Official Journal of the American College of Rheumatology 2003; 49.6:838-842.
  76. van Laar M, Pergolizzi Jr JV, Mellinghoff HU, Merchante IM, Nalamachu S, O'Brien J, Perrot S, Raffa RB. Pain treatment in arthritis-related pain: beyond NSAIDs. The open rheumatology journal. 2012; 6:320.
  77. van Laar M, Pergolizzi Jr JV, Mellinghoff HU, Merchante IM, Nalamachu S, O'Brien J, Perrot S, Raffa RB. Pain treatment in arthritis-related pain: beyond NSAIDs. The open rheumatology journal. 2012; 6:320.
  78. Vignon E. Radiographic issues in imaging the progression of hip and knee osteoarthritis. J Rheumatol Suppl 2004; 70:36–44.
  79. Wandel S, Juni P, Tendal B, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. Br Med J. 2010 ; 341:c4675.
  80. Wu D, Huang Y, Gu Y, Fan W. Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials. Int J Clin Pract. 2013; 67:585-594.
  81. Zhang C, Xie Y, Luo X, Ji Q, Lu C, He C, Wang P. Effects of therapeutic ultrasound on pain, physical functions and safety outcomes in patients with knee osteoarthritis: a systematic review and meta-analysis. Clinical rehabilitation. 2016; 30(10):960-71.
  82. Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis. 2005; 64:669-681.
  83. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16:137-162
  84. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence Osteoarthritis Cartilage, 2007; 15:981-1000.
  85. Георгиев Ц. Гонартроза – монография. Аквапринт 2019.
  86. Рашков Р. и сътр. Остеоартроза – В: Практическо ръководство по ревматология: Допълнение I. София 2016, с. 284-296.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.